Cognition Therapeutics, Inc. (CGTX) Operating cash flow 2020–2025
Cognition Therapeutics, Inc. (CGTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.6MFY2025 · since FY2020: -$3.4M → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +13.6% |
| FY2024 | -$28.5M | -77.8% |
| FY2023 | -$16.0M | +13.6% |
| FY2022 | -$18.5M | -410.4% |
| FY2021 | -$3.6M | -5.8% |
| FY2020 | -$3.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGTX financial trends
CGTX RevenueCGTX Net incomeCGTX Net marginCGTX Gross profitCGTX Gross marginCGTX Operating incomeCGTX Operating marginCGTX Free cash flowCGTX Capital expendituresCGTX Return on equityCGTX Stock buybacksCGTX Dividends paidCGTX Total assetsCGTX Total liabilitiesCGTX Shareholders’ equityCGTX overview →